Pexa-Vec/Nexavar Combination Fails Phase III Trial in Liver Cancer
Evolving role of Sorafenib in the management of hepatocellular carcinoma
Sorafenib Pharmacodynamics
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
Mechanism of Action | Multikinase Inhibitors
Sorafenib (Nexavar) - Oncology Nurse Advisor
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
Sorafenib: 10 years after the first pivotal trial | Future Oncology
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Mechanism of Action | NEXAVAR® (sorafenib) Global HCP Website
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Sorafenib (NEXAVAR)®
Systemic Therapies in Hepatocellular Carcinoma
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
IJMS | Free Full-Text | The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance | HTML
Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram
